Naphazoline/pheniramine

Naphazoline/pheniramine, sold under the brand name Naphcon-A among others, is a combination eye drop used to help the symptoms of allergic conjunctivitis such as from hay fever.[1] It contains naphazoline and pheniramine.[1][2] It is used as an eye drop.[2] Use is not recommended for more than three days.[3]

Naphazoline/pheniramine
Combination of
NaphazolineVasoconstrictor
PheniramineAntihistamine
Clinical data
Trade namesNaphcon-A, Opcon-A, Visine-A, others
AHFS/Drugs.comMultum Consumer Information
Routes of
administration		Eye drop
Legal status
Legal status
Identifiers
CAS Number

Side effects may include allergic reactions, eye pain, and dilated pupils.[1][4][3] It is unclear if use in pregnancy is safe.[2] Nephazoline works by resulting in constriction of blood vessels thus decreasing redness while pheniramine works by blocking the effects of histamine to stop itching.[2]

The combination was approved for medical use in the United States in 1994.[5][6][2] It is available over the counter.[5][6][1] In 2017, it was the 203rd most commonly prescribed medication in the United States, with more than two million prescriptions.[7][6]

Medical use

It is administered topically with one to two drops applied to the affected eye(s) up to four times daily.[1]

Adverse effects

References
  1. "Naphcon A- naphazoline hydrochloride and pheniramine maleate solution/ drops". DailyMed. 16 September 2019. Retrieved 10 August 2020.
  2. "Naphazoline and pheniramine ophthalmic Uses, Side Effects & Warnings". Drugs.com. Retrieved 19 April 2019.
  3. Kizior RJ, Hodgson BB (2014). Saunders Nursing Drug Handbook 2015 - E-Book. Elsevier Health Sciences. p. 163. ISBN 9780323280181.
  4. "Naphazoline/pheniramine ophthalmic Side Effects in Detail". Drugs.com. Retrieved 19 April 2019.
  5. "Naphcon-A: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 19 April 2020.
  6. "Naphazoline Hydrochloride; Pheniramine Maleate - Drug Usage Statistics". ClinCalc. Retrieved 11 April 2020.
  7. "The Top 300 of 2020". ClinCalc. Retrieved 11 April 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.